secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVVITY, INC. (RVTY)
CIK:        0000031791
Form:       8-K
Filed at:   2025-01-13T23:59:59+00:00
Accession:  0000031791-25-000003
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Revvity provides preliminary Q4 revenue ~$730M, 6% organic growth; EPS guidance reaffirmed
--------------------------------------------------------------------------------

- Q4 preliminary revenue ~$730M; reported growth ~5%, organic ~6% vs. prior year.
- Full-year 2024 adjusted EPS expected to meet or exceed guidance provided Nov 4, 2024.
- Q4 and full-year 2024 results to be released Jan 31, 2025; conference call at 8am ET.
- CEO Prahlad Singh to present at J.P. Morgan Healthcare Conference on Jan 13, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/31791/000003179125000003/0000031791-25-000003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/31791/000003179125000003/pki-20250112.htm
  HTML page:      https://secwatch.observer/filing/0000031791-25-000003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer